Clinical trial

A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to Methotrexate

NCT02960438

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-10-20

PhasePHASE2

Study timeline

Study start (actual)2016-10-20Date precision: day

Registry last updated2021-06-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

E6011DRUG

PlaceboDRUG

Sponsors & collaborators

Eisai Co., Ltd.lead sponsor

Mapped research locations

NagoyaAichi-ken, Japan4 SapporoHokkaido, Japan3 HiroshimaJapan3 YokohamaKanagawa, Japan2 FukuokaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02960438 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.